$CLX
CLOROX CO /DE/

2023 Q4 Form 10-Q Financial Statement

#000002107623000048 Filed on November 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023 Q2
Revenue $1.990B $1.386B $2.019B
YoY Change 16.03% -20.34% 12.1%
Cost Of Revenue $1.124B $854.0M $1.157B
YoY Change 2.65% -23.34% 2.12%
Gross Profit $866.0M $532.0M $862.0M
YoY Change 39.68% -15.02% 29.04%
Gross Profit Margin 43.52% 38.38% 42.69%
Selling, General & Admin $322.0M $276.0M $540.0M
YoY Change 14.18% 5.75% 19.73%
% of Gross Profit 37.18% 51.88% 62.65%
Research & Development $32.00M $29.00M $38.00M
YoY Change -3.03% -9.38% 11.76%
% of Gross Profit 3.7% 5.45% 4.41%
Depreciation & Amortization $57.00M $61.00M $62.00M
YoY Change -1.72% 8.93% 8.77%
% of Gross Profit 6.58% 11.47% 7.19%
Operating Expenses $354.0M $305.0M $604.0M
YoY Change 12.38% 4.1% 20.32%
Operating Profit $512.0M $227.0M $258.0M
YoY Change 67.87% -31.83% 55.42%
Interest Expense $26.00M $21.00M -$21.00M
YoY Change 13.04% -4.55% -43.24%
% of Operating Profit 5.08% 9.25% -8.14%
Other Income/Expense, Net
YoY Change
Pretax Income $136.0M $29.00M $237.0M
YoY Change 4.62% -75.0% 83.72%
Income Tax $40.00M $4.000M $56.00M
% Of Pretax Income 29.41% 13.79% 23.63%
Net Earnings $93.00M $22.00M $176.0M
YoY Change -6.06% -74.12% 74.26%
Net Earnings / Revenue 4.67% 1.59% 8.72%
Basic Earnings Per Share $0.75 $0.17
Diluted Earnings Per Share $0.75 $0.17 $1.41
COMMON SHARES
Basic Shares Outstanding 124.1M shares 123.8M shares 123.6M shares
Diluted Shares Outstanding 124.6M shares 124.7M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $355.0M $518.0M $367.0M
YoY Change 111.31% 86.33% 100.55%
Cash & Equivalents $355.0M $518.0M $367.0M
Short-Term Investments
Other Short-Term Assets $115.0M $204.0M $77.00M
YoY Change 1.77% 72.88% -27.36%
Inventory $655.0M $710.0M $696.0M
Prepaid Expenses
Receivables $679.0M $581.0M $688.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.804B $1.911B $1.828B
YoY Change 11.22% 8.39% 5.97%
LONG-TERM ASSETS
Property, Plant & Equipment $1.314B $1.317B $1.691B
YoY Change -0.61% -0.38% 26.76%
Goodwill $1.252B $1.246B $1.252B
YoY Change -19.38% -19.4% -19.64%
Intangibles $712.0M
YoY Change -19.46%
Long-Term Investments $43.00M
YoY Change -17.31%
Other Assets $486.0M $486.0M $462.0M
YoY Change 46.83% 56.27% 46.67%
Total Long-Term Assets $4.104B $4.080B $4.117B
YoY Change -7.21% -7.06% -7.13%
TOTAL ASSETS
Total Short-Term Assets $1.804B $1.911B $1.828B
Total Long-Term Assets $4.104B $4.080B $4.117B
Total Assets $5.908B $5.991B $5.945B
YoY Change -2.27% -2.63% -3.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.649B $1.678B $1.659B
YoY Change 3.78% 5.93% 72.81%
Accrued Expenses $92.00M $88.00M $87.00M
YoY Change 15.0% 12.82% 11.54%
Deferred Revenue
YoY Change
Short-Term Debt $247.0M $347.0M $50.00M
YoY Change 18.18% -0.29% -78.9%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $2.022B $2.228B $1.917B
YoY Change 7.67% 10.85% 7.46%
LONG-TERM LIABILITIES
Long-Term Debt $2.479B $2.478B $2.477B
YoY Change 0.12% 0.12% 0.12%
Other Long-Term Liabilities $852.0M $837.0M $1.135B
YoY Change 3.15% 3.98% 43.49%
Total Long-Term Liabilities $3.331B $3.315B $3.612B
YoY Change 0.88% 1.07% 10.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.022B $2.228B $1.917B
Total Long-Term Liabilities $3.331B $3.315B $3.612B
Total Liabilities $5.690B $5.860B $5.725B
YoY Change 2.45% 3.59% 5.45%
SHAREHOLDERS EQUITY
Retained Earnings $241.0M $299.0M $583.0M
YoY Change -69.18% -64.06% -44.37%
Common Stock $1.376B $1.377B $1.376B
YoY Change 2.84% 4.0% 3.23%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.205B $1.219B $1.246B
YoY Change -7.09% -7.3% -7.43%
Treasury Stock Shares
Shareholders Equity $53.00M -$37.00M $220.0M
YoY Change
Total Liabilities & Shareholders Equity $5.908B $5.991B $5.945B
YoY Change -2.27% -2.63% -3.46%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $93.00M $22.00M $176.0M
YoY Change -6.06% -74.12% 74.26%
Depreciation, Depletion And Amortization $57.00M $61.00M $62.00M
YoY Change -1.72% 8.93% 8.77%
Cash From Operating Activities $153.0M $20.00M $430.0M
YoY Change -26.79% -88.76% 28.36%
INVESTING ACTIVITIES
Capital Expenditures $52.00M $24.00M $84.00M
YoY Change -223.81% -47.83% -206.33%
Acquisitions
YoY Change
Other Investing Activities $19.00M -$1.000M $3.000M
YoY Change 0.0% -82.35%
Cash From Investing Activities -$33.00M -$23.00M -$81.00M
YoY Change -21.43% -48.89% 30.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -259.0M $155.0M -227.0M
YoY Change -7.5% -542.86% -30.37%
NET CHANGE
Cash From Operating Activities 153.0M $20.00M 430.0M
Cash From Investing Activities -33.00M -$23.00M -81.00M
Cash From Financing Activities -259.0M $155.0M -227.0M
Net Change In Cash -139.0M $152.0M 122.0M
YoY Change 23.01% 61.7% -330.19%
FREE CASH FLOW
Cash From Operating Activities $153.0M $20.00M $430.0M
Capital Expenditures $52.00M $24.00M $84.00M
Free Cash Flow $101.0M -$4.000M $346.0M
YoY Change -59.76% -103.03% -16.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration
SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent
CY2023Q2 us-gaap Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration
SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent
CY2023Q3 us-gaap Interest Expense
InterestExpense
21000000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
22000000 usd
CY2023Q3 clx Other Expense Income Net
OtherExpenseIncomeNet
12000000 usd
CY2022Q3 clx Other Expense Income Net
OtherExpenseIncomeNet
34000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
116000000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
25000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
87000000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3000000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
22000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
85000000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123973000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123339000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124650000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
123914000 shares
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
24000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
51000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
49000000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
518000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
367000000 usd
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
581000000 usd
CY2023Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
688000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
710000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
696000000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
102000000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
77000000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1911000000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1828000000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2768000000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2705000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1317000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1345000000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
328000000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
299000000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
583000000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6740113 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6921439 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
1219000000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1246000000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1245000000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
346000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1246000000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
1252000000 usd
CY2023Q3 clx Trademarks Net
TrademarksNet
541000000 usd
CY2023Q2 clx Trademarks Net
TrademarksNet
543000000 usd
CY2023Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
162000000 usd
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
169000000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
486000000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
462000000 usd
CY2023Q3 us-gaap Assets
Assets
5991000000 usd
CY2023Q2 us-gaap Assets
Assets
5945000000 usd
CY2023Q3 us-gaap Commercial Paper
CommercialPaper
347000000 usd
CY2023Q2 us-gaap Commercial Paper
CommercialPaper
50000000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
88000000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
87000000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1678000000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1659000000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
115000000 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
121000000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2228000000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1917000000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2478000000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2477000000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
290000000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
310000000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
837000000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
825000000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
27000000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
28000000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
5860000000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
5557000000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
130741461 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
130741461 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
124001348 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123820022 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
131000000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
131000000 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1246000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-494000000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-493000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-37000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
220000000 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
168000000 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
168000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
131000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
388000000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5991000000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5945000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
25000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
87000000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
61000000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
56000000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
13000000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
10000000 usd
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5000000 usd
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5000000 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000000 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-16000000 usd
CY2023Q3 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-108000000 usd
CY2022Q3 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-63000000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14000000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6000000 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
22000000 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
30000000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-138000000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-28000000 usd
CY2023Q3 clx Operating Lease Rightof Use Asset And Liability Net
OperatingLeaseRightofUseAssetAndLiabilityNet
-1000000 usd
CY2022Q3 clx Operating Lease Rightof Use Asset And Liability Net
OperatingLeaseRightofUseAssetAndLiabilityNet
1000000 usd
CY2023Q3 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-8000000 usd
CY2022Q3 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
14000000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
178000000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24000000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46000000 usd
CY2023Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1000000 usd
CY2022Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1000000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45000000 usd
CY2023Q3 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
298000000 usd
CY2022Q3 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
111000000 usd
CY2023Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
149000000 usd
CY2022Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
145000000 usd
CY2023Q3 clx Issuance Of Common Stock For Employee Stock Plans And Other
IssuanceOfCommonStockForEmployeeStockPlansAndOther
6000000 usd
CY2022Q3 clx Issuance Of Common Stock For Employee Stock Plans And Other
IssuanceOfCommonStockForEmployeeStockPlansAndOther
-1000000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
155000000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35000000 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
152000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
94000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
368000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
186000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
520000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
280000000 usd
CY2023Q3 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
119000000 usd
CY2023Q2 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
220000000 usd
CY2023 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
60000000 usd
CY2023Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0 usd
CY2022Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
19000000 usd
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
60000000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
28000000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
21000000 usd
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
7000000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
618000000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
595000000 usd
CY2023Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
178000000 usd
CY2023Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
182000000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
20000000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8000000 usd
CY2023Q3 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
104000000 usd
CY2023Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
87000000 usd
CY2023Q3 clx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
712000000 usd
CY2023Q2 clx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
698000000 usd
CY2023Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
2000000 usd
CY2023Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
2000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
710000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
696000000 usd
CY2023Q3 us-gaap Maximum Length Of Time Foreign Currency Cash Flow Hedge
MaximumLengthOfTimeForeignCurrencyCashFlowHedge
P2Y
CY2023Q3 us-gaap Maximum Length Of Time Hedged In Interest Rate Cash Flow Hedge1
MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1
P3Y
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-2000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
8000000 usd
CY2023Q3 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
13000000 usd
CY2023Q3 clx Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits Amount
DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount
0 usd
CY2023Q2 clx Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits Amount
DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimitsAmount
1000000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.146
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123973000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123339000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
677000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
575000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124650000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
123914000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2220000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2983000 shares
CY2023Q3 us-gaap Profit Loss
ProfitLoss
25000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
87000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-29000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-8000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-11000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
24000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
51000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
49000000 usd
CY2023Q3 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
24000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
729000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
87000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36000000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.36
CY2022Q3 us-gaap Dividends
Dividends
293000000 usd
CY2022Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5000000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10000000 usd
CY2022Q3 clx Other Employee Stock Plan Activities Amount
OtherEmployeeStockPlanActivitiesAmount
4000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
496000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
388000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
25000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.40
CY2023Q3 us-gaap Dividends
Dividends
300000000 usd
CY2023Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3000000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000000 usd
CY2023Q3 clx Other Employee Stock Plan Activities Amount
OtherEmployeeStockPlanActivitiesAmount
9000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
131000000 usd
CY2023Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
28000000 usd
CY2023Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
28000000 usd
CY2023Q3 clx Letter Of Credit Borrowing Capacity
LetterOfCreditBorrowingCapacity
15000000 usd
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
0 usd
CY2023Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 reportablesegment
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1386000000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1740000000 usd
CY2023Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
10000000 usd
CY2022Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
2000000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
21000000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
22000000 usd
CY2022Q3 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0 usd
CY2023Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0 usd
CY2022Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
19000000 usd
CY2023Q3 clx Digital Capabilities And Productivity Enhancements Expense
DigitalCapabilitiesAndProductivityEnhancementsExpense
27000000 usd
CY2022Q3 clx Digital Capabilities And Productivity Enhancements Expense
DigitalCapabilitiesAndProductivityEnhancementsExpense
20000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
116000000 usd
CY2023Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
0 usd
CY2022Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
19000000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.40
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.36
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
clx-20230930_cal.xml Edgar Link unprocessable
0000021076-23-000048-index-headers.html Edgar Link pending
0000021076-23-000048-index.html Edgar Link pending
0000021076-23-000048.txt Edgar Link pending
0000021076-23-000048-xbrl.zip Edgar Link pending
clx-20230930.htm Edgar Link pending
clx-20230930_def.xml Edgar Link unprocessable
clx-20230930.xsd Edgar Link pending
clx-20230930_g1.jpg Edgar Link pending
clxq1fy24ex101annualincent.htm Edgar Link pending
clxq1fy24ex311ceocertifica.htm Edgar Link pending
clxq1fy24ex312cfocertifica.htm Edgar Link pending
clxq1fy24ex32ceocfocertifi.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
clx-20230930_lab.xml Edgar Link unprocessable
clx-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clx-20230930_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending